These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24861910)

  • 1. Antiplatelet therapy during perioperative period: double-edged sword.
    Kozuma K
    J Cardiol; 2014 Nov; 64(5):331-3. PubMed ID: 24861910
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversations in cardiology: bridging antiplatelet therapy before surgery.
    Kern MJ; Applegate RJ; Bell M; Brilakis ES; Butman SM; Bach RG; Kaul P; Klein LW; Krucoff MW; Moore JA; Price MJ; Rao SV; Stone GW; Uretsky BF
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):748-52. PubMed ID: 24395180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thirty days only double antiplatelet therapy after drug-eluting stenting: could a 'short-term' treatment be advantageous?
    Casella G; Resciniti E; Gallo P
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e21-e25. PubMed ID: 29045308
    [No Abstract]   [Full Text] [Related]  

  • 4. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
    Li J; Ju J; Chen Z; Liu J; Lu F; Gao R; Xu H
    Trials; 2018 Feb; 19(1):93. PubMed ID: 29415754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should all stent patients have prolonged dual antiplatelet therapy?
    Kirtane AJ; King SB
    JACC Cardiovasc Interv; 2015 May; 8(6):873-875. PubMed ID: 25999115
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleeding versus thrombosis: role of short DAPT in complex lesions.
    Calcagno S; Lucisano L; Mancone M; Cavallo E; Pennacchi M; Stio RE; Sardella G
    Minerva Cardioangiol; 2015 Dec; 63(6):533-46. PubMed ID: 26334115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
    Bagai A; Bhatt DL; Eikelboom JW; Mancini GB; Cohen EA; Vijayaraghavan R; Cheema AN; Udell JA; Niznick J; Tanguay JF; Verma S; Mehta SR
    Circulation; 2016 May; 133(21):2094-8. PubMed ID: 27217435
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.
    Brener SJ; Serruys PW; Morice MC; Mehran R; Kappetein AP; Sabik JF; Liu Y; Dressler O; Ben-Yehuda O; Stone GW
    J Am Coll Cardiol; 2018 Oct; 72(17):2086-2087. PubMed ID: 30336833
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiplatelet therapy in acute coronary syndromes.
    Aragam KG; Bhatt DL
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):24-42. PubMed ID: 20924098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the Role of Cangrelor in Patients Undergoing PCI?
    Droppa M; Geisler T
    Curr Vasc Pharmacol; 2018; 16(5):484-489. PubMed ID: 29345586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The CHAMPION PHOENIX study].
    Musumeci G; Limbruno U
    G Ital Cardiol (Rome); 2013 Oct; 14(10):641-6. PubMed ID: 24121887
    [No Abstract]   [Full Text] [Related]  

  • 12. In-hospital bleeding events in acute coronary syndrome patients undergoing percutaneous coronary intervention in the era of novel P2Y12 inhibitors: insights from the GReek AntiPlatelet rEgistry-GRAPE.
    Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Karayannis G; Angelidis C; Stavrou K; Vavuranakis M; Goudevenos JA; Stefanadis C; Alexopoulos D
    Int J Cardiol; 2014 Jun; 174(1):160-2. PubMed ID: 24726352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Perioperative management and postoperative complication rates of patients on dual antiplatelet therapies after coronary drug eluting stent implantation].
    Komiya R; Kamintani K; Kubo E; Hattori M; Kataoka H; Iwase Y; Miyoshi H; Minami M; Kato S; Arai R; Yoshida H
    Masui; 2014 Jun; 63(6):629-35. PubMed ID: 24979851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
    Alexopoulos D; Goudevenos JA; Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Parissis H; Ntalas IV; Angelidis C; Petousis S; Vavuranakis M; Hahalis G; Stefanadis C;
    Int J Cardiol; 2013 Oct; 168(6):5329-35. PubMed ID: 23978364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis.
    Geng X; Zhang YN; Cui W
    J Int Med Res; 2020 Apr; 48(4):300060520915052. PubMed ID: 32270731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y12 inhibitors in acute coronary syndrome: when to give them and when to prolong their use.
    Grotti S; Bolognese L
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e9-e12. PubMed ID: 29538137
    [No Abstract]   [Full Text] [Related]  

  • 18. ADP-receptor inhibitors in the perioperative period: the good, the bad, and the ugly.
    Oprea AD; Popescu WM
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):779-95. PubMed ID: 23648080
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet inhibition and bleeding complications in cardiac surgery: A review.
    Hansson EC; Jeppsson A
    Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.